270 related articles for article (PubMed ID: 32315771)
1. Circular RNA expression profile of Alzheimer's disease and its clinical significance as biomarkers for the disease risk and progression.
Li Y; Fan H; Sun J; Ni M; Zhang L; Chen C; Hong X; Fang F; Zhang W; Ma P
Int J Biochem Cell Biol; 2020 Jun; 123():105747. PubMed ID: 32315771
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer's disease.
Li Y; Han X; Fan H; Sun J; Ni M; Zhang L; Fang F; Zhang W; Ma P
Neurosci Lett; 2022 Apr; 776():136531. PubMed ID: 35167942
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
4. Microarray expression profile of circular RNAs and mRNAs in children with systemic lupus erythematosus.
Li S; Zhang J; Tan X; Deng J; Li Y; Piao Y; Li C; Yang W; Mo W; Sun J; Sun F; Han T; Wang J; Kuang W; Li C
Clin Rheumatol; 2019 May; 38(5):1339-1350. PubMed ID: 30628013
[TBL] [Abstract][Full Text] [Related]
5. Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid.
Wiedrick JT; Phillips JI; Lusardi TA; McFarland TJ; Lind B; Sandau US; Harrington CA; Lapidus JA; Galasko DR; Quinn JF; Saugstad JA
J Alzheimers Dis; 2019; 67(3):875-891. PubMed ID: 30689565
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels.
Maxwell TJ; Corcoran C; Del-Aguila JL; Budde JP; Deming Y; Cruchaga C; Goate AM; Kauwe JSK;
Alzheimers Res Ther; 2018 Aug; 10(1):86. PubMed ID: 30153862
[TBL] [Abstract][Full Text] [Related]
7. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
[TBL] [Abstract][Full Text] [Related]
8. Identification of Circulating hsa_circ_0063425 and hsa_circ_0056891 as Novel Biomarkers for Detection of Type 2 Diabetes.
Lu YK; Chu X; Wang S; Sun Y; Zhang J; Dong J; Yan YX
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2688-e2699. PubMed ID: 33608702
[TBL] [Abstract][Full Text] [Related]
9. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics and Experimental Identification of
Ma M; Xie D; Zhao J
J Integr Neurosci; 2023 Jul; 22(4):105. PubMed ID: 37519165
[TBL] [Abstract][Full Text] [Related]
11. Novel circular RNA expression in the cumulus cells of patients with polycystic ovary syndrome.
Ma Z; Zhao H; Zhang Y; Liu X; Hao C
Arch Gynecol Obstet; 2019 Jun; 299(6):1715-1725. PubMed ID: 30941555
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA profile of acute myeloid leukaemia indicates circular RNA annexin A2 as a potential biomarker and therapeutic target for acute myeloid leukaemia.
Ding Y; Dong Y; Lu H; Luo X; Fu J; Xiu B; Liang A; Zhang W
Am J Transl Res; 2020; 12(5):1683-1699. PubMed ID: 32509169
[TBL] [Abstract][Full Text] [Related]
13. Identification of circular RNA Hsa_circ_0001879 and Hsa_circ_0004104 as novel biomarkers for coronary artery disease.
Wang L; Shen C; Wang Y; Zou T; Zhu H; Lu X; Li L; Yang B; Chen J; Chen S; Lu X; Gu D
Atherosclerosis; 2019 Jul; 286():88-96. PubMed ID: 31103880
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive.
Oláh Z; Kálmán J; Tóth ME; Zvara Á; Sántha M; Ivitz E; Janka Z; Pákáski M
J Alzheimers Dis; 2015; 44(4):1303-12. PubMed ID: 25428253
[TBL] [Abstract][Full Text] [Related]
15. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.
Galasko D; Chang L; Motter R; Clark CM; Kaye J; Knopman D; Thomas R; Kholodenko D; Schenk D; Lieberburg I; Miller B; Green R; Basherad R; Kertiles L; Boss MA; Seubert P
Arch Neurol; 1998 Jul; 55(7):937-45. PubMed ID: 9678311
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
[TBL] [Abstract][Full Text] [Related]
17. Expression profile and diagnostic value of circRNAs in peripheral blood from patients with systemic lupus erythematosus.
Luo Q; Li X; Fu B; Zhang L; Fang L; Qing C; Guo Y; Huang Z; Li J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33169172
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of circ_0021739 in Peripheral Blood Mononuclear Cells in Women with Postmenopausal Osteoporosis Is Associated with Reduced Expression of microRNA-194-5p in Osteoclasts.
Guan J; Gan L; Jin D; Wu X; Cheng L; Liu M; Fan Y; Zhou J; Zhang H; Zhang Y; Zhou P
Med Sci Monit; 2021 Apr; 27():e929170. PubMed ID: 33875631
[TBL] [Abstract][Full Text] [Related]
19. Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
Christl J; Verhülsdonk S; Pessanha F; Menge T; Seitz RJ; Kujovic M; Höft B; Supprian T; Lange-Asschenfeldt C
J Alzheimers Dis; 2019; 72(4):1119-1127. PubMed ID: 31683478
[TBL] [Abstract][Full Text] [Related]
20. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]